Lifebank

What Lifebank does

Lifebank (legal entity: Celularity Inc. d/b/a LifebankUSA) is a US-based private stem cell banking company that collects, processes, and cryopreserves hematopoietic stem cells from umbilical cord blood and mesenchymal stem cells from placental blood and tissue for individual family storage. Founded in 1998, acquired by Celgene in 2002, and spun out as Celularity in 2017 with Lifebank retained as a core subsidiary, the company operates a state-of-the-art processing and storage facility in Florham Park, NJ, alongside a Cedar Knolls headquarters. Its patented processing methods for placental blood and tissue preservation are described as unique to the company, with Celularity research indicating a 68% increase in CD34+ cells and 17% increase in TNC when adding placental banking to cord blood alone. The product line includes Cord Blood Banking ($1,274 first-year / $199 annual storage), a comprehensive Cord + Placental Blood and Tissue Package ($3,024 first-year / $449 annual storage), a Sibling Program offering free or discounted services to families with children diagnosed with qualifying diseases (in partnership with Duke University and MD Anderson), and a Donation Program supplying biomaterials for Celularity's cellular therapy research.

The business model is a hybrid direct-to-consumer and healthcare-professional-referred sales motion: expectant parents enroll via the company website (myaccount.lifebankusa.com), phone (877-543-3226), or scheduled Client Services planning sessions, while OBGYNs, midwives, and hospital staff act as both referral sources and the on-site collection channel at delivery. Revenue mechanics combine a one-time enrollment and processing fee ($900–$2,400) with a recurring annual storage annuity ($199–$449) running up to 18 years or longer, creating a long-duration revenue tail per customer. The Sibling Program and Donation Program extend the funnel into specialized medical use cases (blood-related disorders, Cerebral Palsy, Autism) and supply Celularity's regenerative medicine pipeline, including products such as Interfyl and Biovance. Customer segments span expectant parents (primary), healthcare professionals (collection channel), families with diagnosed children (specialized), and placenta donors (research supply). Distribution is US-only with no international presence. The company has reported 99%+ customer satisfaction and 25+ years of operating history, supported by media coverage in Fox Business, NBC, CBS, the Wall Street Journal, the New York Times, and Science AAAS.

Name

Lifebank

Legal name

Celularity Inc. d/b/a LifebankUSA

Website

https://lifebankusa.com

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

11–50 employees

Short description

Lifebank is a US-based private stem cell bank (subsidiary of Celularity) that collects, processes, and cryopreserves newborn cord blood and placental tissue for individual family storage. It serves expectant parents via direct-to-consumer sales and OBGYN/midwife referrals, with patented placental processing as its core differentiator.

Ownership category

akta.pro rank

Product category

Stem Cell Banking

NAICS

Blood and Organ Banks (621991)

SIC

Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE)

akta.pro secondary industries

Stem Cell Therapies (MSC/iPSC/HSC-derived) (HLAAABAE), Cell Banking & Viral Seed Services (MCB/WCB/VSB) (HLAGAGAD), Blood, Organ & Tissue Donation Organizations (BPAGACAJ)

Keywords

• Cord blood banking
• Placental stem cells
• Stem cell preservation
• Newborn stem cells
• Tissue cryopreservation

Headquarters

HQ city

Florham Park

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Supply Chain, Marketing or Sales, Technology or R&D

Revenue model

1. Cord Blood Banking Enrollment and Processing: One-time enrollment and processing fees for cord blood banking services. First-year costs total $1,274 including a $175 non-refundable registration fee, $900 enrollment and processing fee, and $199 annual storage fee.
2. Annual Storage Fees: Recurring annual storage fees for cryopreserved stem cells. Annual storage costs $199 for cord blood alone, totaling $3,582 over 18 years or $3,000 if paid upfront.
3. Placental Blood and Tissue Banking: Enhanced banking service combining cord blood with placental blood and tissue. First-year costs $3,024 including $2,400 enrollment and processing fee plus $449 annual storage. Storage totals $8,082 over 18 years or $7,599 upfront.
4. Placenta Donation Program: Free donation program for eligible clients who meet criteria and donate placenta. Enrollment and processing fee of $500 for qualified donors.
5. Sibling Program Services: Discounted or free services for families with children diagnosed with certain diseases. Traditional program offers free collection, processing, and 5 years storage. Cerebral Palsy and Autism program offers 50% off collection and processing fees.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels8 records

Core offering

Lifebank collects, processes, and cryopreserves hematopoietic stem cells from umbilical cord blood and mesenchymal stem cells from cord tissue, placental blood, and placental tissue for expectant parents. Services are sold as private banking packages, a comprehensive cord-plus-placental package, a discounted Sibling Program for families with affected children, and a Donation Program for public/research contribution, with materials stored at the company's Florham Park, NJ facility.

Product overview

Lifebank is a stem cell banking company offering a family of cord blood and placental banking services. The core offering consists of Cord Blood Banking, which preserves hematopoietic stem cells (HSCs) from umbilical cord blood for treating over 80 FDA-approved diseases. Placental Banking complements this by preserving additional stem cells from placental blood and tissue, including mesenchymal stem cells (MSCs) with regenerative medicine potential. These can be purchased individually or as a combined Cord Blood + Placental Blood and Tissue Package. Lifebank also offers a Sibling Program for families with qualifying medical conditions at discounted rates, and a Donation Program for families choosing to contribute to public stem cell supplies. The company operates under Lifebank By Celularity, leveraging Celularity's patented technologies and state-of-the-art processing and storage facilities in New Jersey.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• 68% increase in CD34+ stem cells when adding placental blood banking to cord blood banking
• +4 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Four partnerships are on record, tiered core and flagship.

• CelularitycoreOthersLifebank is a subsidiary of Celularity Inc., which was spun out from Celgene in 2017. Celularity provides scientific leadership, research capabilities, and advanced cellular therapy development. Robert J. Hariri, M.D., Ph.D. serves as Founder, Chairman, and CEO of Celularity and Lifebank. Lifebank operates as Lifebank By Celularity.
• Duke UniversityflagshipStrategic or Co-development PartnerDuke University has an Expanded Access Protocol for the use of umbilical cord blood infusions to treat children with Cerebral Palsy and Autism. Lifebank's Sibling Program for Cerebral Palsy and Autism offers 50% off services for families participating in this protocol.
• MD Anderson Cancer CenterflagshipStrategic or Co-development PartnerMD Anderson has an Expanded Access Protocol for umbilical cord blood infusions to treat Cerebral Palsy and Autism. Partnered with Lifebank's Sibling Program to provide discounted stem cell banking services.
• Children's Hospital New Orleans / LSUHSCflagshipStrategic or Co-development PartnerDr. Lolie Yu at LSUHSC & Children's Hospital performed the world's first combined cord and placental stem cell transplant in 2008 using Lifebank-processed stem cells for Quentin's treatment of acute lymphoblastic leukemia.

Scale indicators7 records

Recent moves8 records

Expansion highlights4 records

Direct peers

• StemCyte: StemCyte operates both private and public cord blood banking services with an emphasis on cord blood and placental tissue processing. It is a direct competitor in placental-derived stem cell banking, the same differentiated product category where Lifebank holds its patented technology advantage.
• AlphaCord: AlphaCord is a US-based private cord blood bank offering cord blood and tissue banking services to expectant parents. It is a smaller direct peer competing in the same niche private banking segment with similar pricing structures and recurring storage revenue model.
• Cryo-Cell International: Cryo-Cell International is a publicly-traded cord blood banking company offering services similar to Lifebank's core cord blood banking product. It competes in the same DTC private banking market with comparable pricing, processing technology, and recurring storage revenue model.
• ViaCord: ViaCord is a leading private cord blood and cord tissue bank owned by Revvity (formerly PerkinElmer). It directly competes with Lifebank on cord blood banking for expectant parents with comparable pricing tiers, recurring storage fees, and a similar healthcare professional referral GTM motion.
• Cord Blood Registry (CBR): Cord Blood Registry is the largest US private cord blood bank, offering cord blood and cord tissue preservation services to expectant parents. CBR is the most direct competitor to Lifebank, operating with a similar DTC sales model, healthcare professional referral network, and recurring storage revenue structure.

Regional players

• Cells4Life: Cells4Life is the UK's largest private cord blood bank, offering cord blood and tissue storage across multiple international markets. It is comparable to Lifebank in product offering and service tiers but operates in different geographies, serving as a relevant peer for international expansion benchmarking.
• Smart Cells International: Smart Cells is a UK-based private stem cell bank offering cord blood and tissue banking services with international shipping. It is comparable to Lifebank as a private banking competitor serving expectant parents with a similar subscription-based storage model, but operates primarily outside the US.

Broad incumbents

• Celularity Inc. Celularity is Lifebank's parent company and a broader cellular therapy biotech developing placental-derived therapeutics including Interfyl and Biovance. While not a peer in the traditional sense, Celularity is highly relevant as the integrated platform that owns and operates Lifebank and could expand into adjacent regenerative medicine services.

Emerging players

• Cleveland Cord Blood Center: Cleveland Cord Blood Center is a public cord blood bank and research organization collecting donations for transplant and research use. It serves as an adjacent peer representing the public banking model that competes with Lifebank's donation program and broader private banking value proposition.
• New York Blood Center: New York Blood Center operates one of the largest public cord blood banks in the US, including the National Cord Blood Program. While not a direct private competitor, it is a relevant adjacent player representing the public banking alternative that competes for consumer mindshare against Lifebank's private offering.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/lifebankusa
• Facebookfacebook.com/LifebankUSA
• Xx.com/Lifebankusa
• LinkedInlinkedin.com/company/lifebankusa

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lifebank